• Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
  

PubMed=11506965; DOI=10.1016/S0959-8049(01)00154-X
Gemma A., Takenaka K., Hosoya Y., Matuda K., Seike M., Kurimoto F., Ono Y., Uematsu K., Takeda Y., Hibino S., Yoshimura A., Shibuya M., Kudoh S.
Altered expression of several genes in highly metastatic subpopulations of a human pulmonary adenocarcinoma cell line.
Eur. J. Cancer 37:1554-1561(2001)

PubMed=12696064; DOI=10.1002/gcc.10205
Yoshimura A., Gemma A., Hosoya Y., Komaki E., Hosomi Y., Okano T., Takenaka K., Matuda K., Seike M., Uematsu K., Hibino S., Shibuya M., Yamada T., Hirohashi S., Kudoh S.
Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancer.
Genes Chromosomes Cancer 37:159-164(2003)

PubMed=17982658; DOI=10.3892/ijo.31.6.1325
Takemura A., Gemma A., Shibuya M., Matsuda K., Okano T., Nara M., Noro R., Minegishi Y., Yoshimura A., Kudoh S.
Gemcitabine resistance in a highly metastatic subpopulation of a pulmonary adenocarcinoma cell line resistant to gefitinib.
Int. J. Oncol. 31:1325-1332(2007)